Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2021 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2020 Net Income$39.18M$39.18M−11.7% vs Q2 2020 EPS Diluted$0.85$0.85−14.1% vs Q2 2020 Operating Cash Flowderived$51,600,000— The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 9, 2021 · 40 d after period end